Shaping the Sarcopenia Treatment Market in 2025: Biophytis Receives FDA Authorization For Groundbreaking SARA-31 Phase 3 Study

How Big Is the Sarcopenia Treatment Market Expected to Be, and What Will Its Growth Rate Be?
The sarcopenia treatment market has experienced strong growth in recent years. It will grow from $3.52 billion in 2024 to $3.73 billion in 2025, at a CAGR of 6.1%. This growth is due to the aging population, increased awareness and diagnosis, lifestyle changes, public health initiatives, and regulatory approvals.

The sarcopenia treatment market is expected to experience strong growth, reaching $4.72 billion in 2029 at a CAGR of 6.0%. The forecasted growth can be attributed to personalized medicine, nutritional interventions, the rise of digital health platforms, patient education, and global health initiatives. Major trends include personalized therapies, novel drug classes, digital health integration, collaborative research, and expanding R&D efforts.

What Are the Primary Growth Drivers for the Sarcopenia Treatment Market?
The growing incidence of malnutrition is expected to accelerate the growth of the sarcopenia treatment market. Malnutrition encompasses deficiencies, excesses, or imbalances in nutrient intake, contributing to conditions such as undernutrition, obesity, and diet-related diseases. Sarcopenia treatment addresses malnutrition and muscle loss in older adults through nutritional therapy and exercise interventions aimed at improving muscle mass and overall health. For example, in December 2023, the World Health Organization (WHO), a Switzerland-based United Nations agency, reported that malnutrition remained a major global health concern, affecting 462 million underweight individuals and 149 million children under five suffering from stunted growth in 2022. As a result, the increasing incidence of malnutrition is propelling the growth of the sarcopenia treatment market.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13926&type=smp

Who Are the Dominant Companies Influencing Sarcopenia Treatment Market Trends?
Major companies operating in the sarcopenia treatment market report are Pfizer Inc., F-Hoffmann La-Roche, Merck Sharp & Dohme Corp. (Merck & Co.), AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., Abbott Laboratories Inc., GlaxoSmithKline plc, Eli Lilly and Company, BASF SE, Nestle Health Science, Haleon Group of Companies, Regeneron Pharmaceuticals Inc., DSM, American Way (Amway) Corporation, Perrigo Company PLC, Intas Pharmaceuticals Ltd, Zydus Lifesciences, Fermenta Biotech Limited, Metagenics LLC, Ion Labs Inc., Makers Nutrition LLC, NutraScience Labs, AstaReal AB, NutraPak USA, BioThrive Sciences, Wellona Pharma, Healing Pharma India Pvt. Ltd., Nutrafill

How Is the Sarcopenia Treatment Market Evolving?
Key companies in the sarcopenia treatment market are emphasizing the advancement of multiple clinical studies to develop improved treatment options. A clinical study systematically investigates human subjects to assess the safety, efficacy, and outcomes of a medical intervention. For instance, in September 2023, Biophytis, a France-based biotechnology company, secured authorization from the Food and Drug Administration (FDA) to initiate the SARA-31 Phase 3 study for sarcopenia. This study aims to evaluate the effectiveness and safety of Sarconeos (BIO101) in treating sarcopenic patients at risk of motor disability. Representing a major breakthrough in pharmaceutical and technological treatment approaches, this is the first-ever Phase 3 sarcopenia study authorized by the FDA. The trial will involve approximately 900 patients aged 65 and older with sarcopenia, reduced walking speed, and decreased hand grip strength. The primary objective is to assess the risk of major mobility disability (MMD), along with evaluating walking speed, hand grip strength, and patient-reported quality of life.

What Are the Different Segmentations in the Sarcopenia Treatment Market?
The sarcopenia treatment market covered in this report is segmented -

1) By Treatment Type: Protein Supplements, Vitamin B12 Supplements, Vitamin D And Calcium Supplements, Other Treatment Types
2) By Type: Primary Sarcopenia, Secondary Sarcopenia
3) By Route Of Administration: Oral, Parenteral, Enteral
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels

Subsegments:
1) By Protein Supplements: Whey Protein, Casein Protein, Soy Protein, Plant-Based Protein
2) By Vitamin B12 Supplements: Cyanocobalamin, Methylcobalamin
3) By Vitamin D And Calcium Supplements: Vitamin D2, Vitamin D3, Calcium Carbonate, Calcium Citrate
4) By Other Treatment Types: Exercise Programs, Hormone Replacement Therapy, Other Nutritional Interventions

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/sarcopenia-treatment-global-market-report

Which Region Is at the Forefront of the Sarcopenia Treatment Market?
North America was the largest region in the sarcopenia treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sarcopenia treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Is Covered In The Sarcopenia Treatment Global Market Report?

- Market Size Analysis: Analyze the Sarcopenia Treatment Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Sarcopenia Treatment Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Sarcopenia Treatment Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Sarcopenia Treatment Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13926

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.